Innovative Tools and Strategies for Metabolomics Data Analysis [PDF]
La metabolòmica és un bon enfocament per comprendre els fenotips. Això és valuós en aplicacions biomèdiques, ja que els metabòlits proporcionen informació sobre els processos bioquímics en temps real.
Llambrich Rodriguez, Maria
core
Développement d'outils computationnels pour une approche de métabolomique non ciblée par spectrométrie de masse à haut débit [PDF]
La métabolomique est l'étude des petites molécules produites par un système biologique. L'objectif principal des études en métabolomique non ciblées est la recherche d'une signature moléculaire, à base de biomarqueurs, permettant de distinguer deux ...
Plante, Pier-Luc, Plante, Pier-Luc
core +1 more source
Effect of farnesyltransferase inhibitors on SARS-CoV-2. [PDF]
J Glob Antimicrob Resist, 2023 Weber L +5 more
europepmc +1 more source
Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study. [PDF]
Psychiatry Clin Neurosci, 2023 Kishi T +5 more
europepmc +1 more source
Amurensin G Sensitized Cholangiocarcinoma to the Anti-Cancer Effect of Gemcitabine via the Downregulation of Cancer Stem-like Properties. [PDF]
Nutrients, 2023 Na YJ, Lee HK, Choi KC.
europepmc +1 more source
Sensory evaluation of the bitterness of asenapine using D-sorbitol pretreatment: single-blind, placebo-controlled, crossover trial. [PDF]
BMC Psychiatry, 2023 Wada S +8 more
europepmc +1 more source
Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine. [PDF]
BMJ Case Rep, 2021 Takao N, Murai T, Fujiwara H.
europepmc +1 more source
Long-term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow-up for 52 weeks (P06125)-Secondary publication. [PDF]
Neuropsychopharmacol Rep, 2023 Kinoshita T +4 more
europepmc +1 more source
The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B. [PDF]
Nucleus, 2023 Odinammadu KO +5 more
europepmc +1 more source
Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation. [PDF]
Circulation, 2023 Gordon LB +10 more
europepmc +1 more source